The Key Roles of Mycobacterium tuberculosis FadD23 C-terminal Domain in Catalytic Mechanisms

Sulfolipid-1 (SL-1) is located in the Mycobacterium tuberculosis (M. tb) cell wall, and is essential for pathogen virulence and intracellular growth. Multiple proteins (e.g., Pks2, FadD23, PapA1, and MmpL8) in the SL-1 synthesis pathway can be treated as drug targets, but, to date, their structures have not been solved. The crystal structures of FadD23 bound to ATP or hexadecanoyl adenylate was determined in this study. We have also investigated long-chain saturated fatty acids as biological substrates of FadD23 through structural, biological, and chemical analyses. The mutation at the active site of FadD23 greatly influences enzymatic activity. Meanwhile, the FadD23 N-terminal domain alone cannot bind palmitic acid without C-terminal domain facilitation since it is almost inactive after removing the C-terminal domain. FadD23 is the first protein in the SL-1 synthesis pathway whose structure has been solved. These results reveal the importance of the C-terminal domain in the catalytic mechanism.

[1]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[2]  C. Aldrich,et al.  Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis. , 2020, European journal of medicinal chemistry.

[3]  M. Shiloh,et al.  Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough , 2020, Cell.

[4]  G. Minasov,et al.  Structure of the Essential Mtb FadD32 Enzyme: A Promising Drug Target for Treating Tuberculosis. , 2016, ACS infectious diseases.

[5]  L. Mourey,et al.  Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria* , 2016, The Journal of Biological Chemistry.

[6]  Xavier Robert,et al.  Deciphering key features in protein structures with the new ENDscript server , 2014, Nucleic Acids Res..

[7]  Feng Wang,et al.  Structures of Mycobacterium tuberculosis FadD10 Protein Reveal a New Type of Adenylate-forming Enzyme* , 2013, The Journal of Biological Chemistry.

[8]  R. Sankaranarayanan,et al.  Molecular basis of the functional divergence of fatty acyl-AMP ligase biosynthetic enzymes of Mycobacterium tuberculosis. , 2012, Journal of molecular biology.

[9]  C. Bertozzi,et al.  Elucidation and Chemical Modulation of Sulfolipid-1 Biosynthesis in Mycobacterium tuberculosis , 2011, The Journal of Biological Chemistry.

[10]  D. Mohanty,et al.  Fatty acyl-AMP ligases and polyketide synthases are unique enzymes of lipid biosynthetic machinery in Mycobacterium tuberculosis. , 2011, Tuberculosis.

[11]  J. M. Sauder,et al.  Structural and functional studies of fatty acyl adenylate ligases from E. coli and L. pneumophila. , 2010, Journal of molecular biology.

[12]  C. Aldrich,et al.  A continuous kinetic assay for adenylation enzyme activity and inhibition. , 2010, Analytical biochemistry.

[13]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[14]  F. von Delft,et al.  Structural snapshots for the conformation-dependent catalysis by human medium-chain acyl-coenzyme A synthetase ACSM2A. , 2009, Journal of molecular biology.

[15]  O. Burlet-Schiltz,et al.  The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosis* , 2009, The Journal of Biological Chemistry.

[16]  David H Sherman,et al.  Structural basis for binding specificity between subclasses of modular polyketide synthase docking domains. , 2009, ACS chemical biology.

[17]  R. Wu,et al.  Structural characterization of a 140 degrees domain movement in the two-step reaction catalyzed by 4-chlorobenzoate:CoA ligase. , 2008, Biochemistry.

[18]  R. Stokes,et al.  Selection of transposon mutants of Mycobacterium tuberculosis with increased macrophage infectivity identifies fadD23 to be involved in sulfolipid production and association with macrophages. , 2007, Microbiology.

[19]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[20]  C. Bertozzi,et al.  PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis virulence factor Sulfolipid-1 , 2007, Proceedings of the National Academy of Sciences.

[21]  Andrew M Gulick,et al.  Biochemical and crystallographic analysis of substrate binding and conformational changes in acetyl-CoA synthetase. , 2007, Biochemistry.

[22]  D. Mohanty,et al.  Versatile polyketide enzymatic machinery for the biosynthesis of complex mycobacterial lipids. , 2007, Natural product reports.

[23]  C. Bertozzi,et al.  Sulfate Metabolism in Mycobacteria , 2006, Chembiochem : a European journal of chemical biology.

[24]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[25]  J. Berger,et al.  Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis , 2004, Nature Structural &Molecular Biology.

[26]  Petri Kursula,et al.  XDSi: a graphical interface for the data processing program XDS , 2004 .

[27]  Rajesh S. Gokhale,et al.  Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria , 2004, Nature.

[28]  H. Berg,et al.  Functional interactions between receptors in bacterial chemotaxis , 2004, Nature.

[29]  Carolyn R Bertozzi,et al.  MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Sprecher,et al.  The Mycobacterium tuberculosis pks2 Gene Encodes the Synthase for the Hepta- and Octamethyl-branched Fatty Acids Required for Sulfolipid Synthesis* , 2001, The Journal of Biological Chemistry.

[31]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[32]  B. Andersen,et al.  Effect of Mycobacterium tuberculosis-derived sulfolipid I on human phagocytic cells , 1988, Infection and immunity.

[33]  A. Vatter,et al.  Polyanionic Agents as Inhibitors of Phagosome‐Lysosome Fusion in Cultured Macrophages: Evolution of an Alternative Interpretation , 1987, Journal of leukocyte biology.

[34]  Masahiko Kato,et al.  Synergistic Action of Cord Factor and Mycobacterial Sulfatides on Mitochondria , 1974, Infection and immunity.

[35]  E. Lederer,et al.  Sulfolipid I of Mycobacterium tuberculosis, strain H37RV. Nature of the acyl substituents. , 1971, Biochemistry.

[36]  M. Goren Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. II. Structural studies. , 1970, Biochimica et biophysica acta.

[37]  C. Dolea,et al.  World Health Organization , 1949, International Organization.